CASES OF RELAPSED AND REFRACTORY B CELL PRECURSOR-ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY

被引：0
|
作者：
Kurita, Daisuke [1 ]
Yamanishi, Jun [1 ]
Osuna, Mitsumasa [1 ]
Ikeda, Junji [1 ]
Tsujimoto, Shinichi [1 ]
Takeuchi, Masanobu [1 ]
Tanoshima, Reo [1 ]
Shiba, Norio [1 ]
机构：
[1] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-076
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia
    Ceppi, Francesco
    Gardner, Rebecca A.
    CANCER JOURNAL, 2019, 25 (03): : 191 - 198
  • [22] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang Xian
    Li Jing-Jing
    Lu Pei-Hua
    中华医学杂志(英文版), 2020, 133 (04) : 474 - 482
  • [23] Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
    Furun An
    Huiping Wang
    Zhenyun Liu
    Fan Wu
    Jiakui Zhang
    Qianshan Tao
    Yingwei Li
    Yuanyuan Shen
    Yanjie Ruan
    Qing Zhang
    Ying Pan
    Weiwei Zhu
    Hui Qin
    Yansheng Wang
    Yongling Fu
    Zhenqing Feng
    Zhimin Zhai
    Nature Communications, 11
  • [24] Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
    Zhang, Xian
    Li, Jing-Jing
    Lu, Pei-Hua
    CHINESE MEDICAL JOURNAL, 2020, 133 (04) : 474 - 482
  • [25] Influence of patient characteristics on chimeric antigen receptor T cell therapy in B-cell acute lymphoblastic leukemia
    An, Furun
    Wang, Huiping
    Liu, Zhenyun
    Wu, Fan
    Zhang, Jiakui
    Tao, Qianshan
    Li, Yingwei
    Shen, Yuanyuan
    Ruan, Yanjie
    Zhang, Qing
    Pan, Ying
    Zhu, Weiwei
    Qin, Hui
    Wang, Yansheng
    Fu, Yongling
    Feng, Zhenqing
    Zhai, Zhimin
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [26] Granulocyte Transfusions in a Patient with Relapsed B-Cell Acute Lymphoblastic Leukemia Status Post Chimeric Antigen Receptor T-Cell Therapy
    Briski, Laurence M.
    Siegfried, Barry
    Yamada, Chisa
    TRANSFUSION, 2017, 57 : 173A - 174A
  • [27] The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia
    McClory, Susan E.
    Maude, Shannon L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1041 - 1052
  • [28] Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia
    Ma, Sha
    Wang, Ying
    Qi, Kunming
    Lu, Wenyi
    Qi, Yuekun
    Cao, Jiang
    Niu, Mingshan
    Li, Depeng
    Sang, Wei
    Yan, Zhiling
    Zhu, Feng
    Cheng, Hai
    Li, Zhenyu
    Zhao, Mingfeng
    Xu, Kailin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (06)
  • [29] Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
    Beyar-Katz, Ofrat
    Rowe, Jacob M.
    HAEMATOLOGICA, 2024, 109 (06) : 1631 - 1633
  • [30] Impact of Treatment with Inotuzumab Ozogamicin before or after Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Rheingold, Susan R.
    Ji, Lingyun
    Gore, Lia
    Xu, Xinxin
    Bhojwani, Deepa
    Shah, Nirali N.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    O'Brien, Maureen M.
    BLOOD, 2023, 142
12345